114 related articles for article (PubMed ID: 38073443)
21. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
22. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
[TBL] [Abstract][Full Text] [Related]
23. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
Radke I; Götte M; Smollich M; Scharle N; Kiesel L; Wülfing P
Arch Gynecol Obstet; 2017 Dec; 296(6):1153-1160. PubMed ID: 28980126
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
25. N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells.
Choi S; Yu J; Kim W; Park KS
Theranostics; 2021; 11(14):6786-6799. PubMed ID: 34093853
[No Abstract] [Full Text] [Related]
26. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
[TBL] [Abstract][Full Text] [Related]
27. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
28. Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity.
Yiin JJ; Hu B; Jarzynka MJ; Feng H; Liu KW; Wu JY; Ma HI; Cheng SY
Neuro Oncol; 2009 Dec; 11(6):779-89. PubMed ID: 20008733
[TBL] [Abstract][Full Text] [Related]
29. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.
Ribeiro AS; Albergaria A; Sousa B; Correia AL; Bracke M; Seruca R; Schmitt FC; Paredes J
Oncogene; 2010 Jan; 29(3):392-402. PubMed ID: 19901964
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
31. The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.
Guo C; Zhu K; Sun W; Yang B; Gu W; Luo J; Peng B; Zheng J
Biochem Biophys Res Commun; 2014 Jan; 443(4):1226-31. PubMed ID: 24393848
[TBL] [Abstract][Full Text] [Related]
32. Post-transcriptional regulation of cadherin-11 expression by GSK-3 and beta-catenin in prostate and breast cancer cells.
Farina AK; Bong YS; Feltes CM; Byers SW
PLoS One; 2009; 4(3):e4797. PubMed ID: 19274078
[TBL] [Abstract][Full Text] [Related]
33. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
[TBL] [Abstract][Full Text] [Related]
34. Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop.
Mukherjee S; Mazumdar M; Chakraborty S; Manna A; Saha S; Khan P; Bhattacharjee P; Guha D; Adhikary A; Mukhjerjee S; Das T
Stem Cell Res Ther; 2014 Oct; 5(5):116. PubMed ID: 25315241
[TBL] [Abstract][Full Text] [Related]
35. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA
J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258
[TBL] [Abstract][Full Text] [Related]
36. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
[TBL] [Abstract][Full Text] [Related]
37. Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.
Wu Y; Ginther C; Kim J; Mosher N; Chung S; Slamon D; Vadgama JV
Mol Cancer Res; 2012 Dec; 10(12):1597-606. PubMed ID: 23071104
[TBL] [Abstract][Full Text] [Related]
38. Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo.
Zhang J; Li K; Zhang Y; Lu R; Wu S; Tang J; Xia Y; Sun J
BMC Cancer; 2019 Jun; 19(1):555. PubMed ID: 31182056
[TBL] [Abstract][Full Text] [Related]
39. ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models.
Parray A; Siddique HR; Kuriger JK; Mishra SK; Rhim JS; Nelson HH; Aburatani H; Konety BR; Koochekpour S; Saleem M
Int J Cancer; 2014 Dec; 135(11):2493-506. PubMed ID: 24752651
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.
Kelly NJ; Varga JFA; Specker EJ; Romeo CM; Coomber BL; Uniacke J
Oncogene; 2018 Feb; 37(5):651-662. PubMed ID: 28991229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
